$0.79
-0.01(-1.04%)
Mkt Cap $449.3K
$0.65
$11.06
52-Week Range
At a Glance
AI-generatedNet losses narrowed 14.2% to -$19.4M due to reduced other expenses from lower debt settlements and equity issuance losses, despite wider operating deficits of -$16.1M from development activities.
8-K
Glucotrack, Inc. announced financial results for the year ended December 31, 2025, reporting a reduced net loss of $19.4 million and cash position of $7.4 million, alongside progress on implantable CBGM technology and $4.0 million private placement.$449.3K
Market Cap
—
Revenue
-$16M
Net Income
Employees11
Fundamentals
How The Business Makes Money
GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.
Industry Medical - Instruments & Supplies
Activity
What Changed Recently
Company Profile
CIK0001506983
ISINUS45824Q8042
CUSIP45824Q804
Phone972 8 675 7878
Address8 Ariel Sharon Street, Or Yehuda, 7760049, IL
SEC EDGAR